I know very well the unbelievable advantage Afrezza has over EVERY other injectible.. but have known that since the hearings before the drug go approved. My question is about the near tripling in value over the last 2 months or so... has nothing t all to do with how great the drug is
I have a lot of options Im using to potentially reduce my exposure for play in 2017 and 2018. Smart investors don't average down.. that's suicidal. You don't but shares of anything when a company's stocks are in a downward trend. You still said nothing factual.. I get that Matt's words are encouraging, but when I was complaining to Matt 6 months ago that I was disappointed that they were not informing the shareholders while the stock was getting slaughtered, as well as the investors, he only saud good things, nothing specific, of course... so again,no facts.
I'm averaged in at $7.20 PPS. I'm in a lot of pain and while it has been exciting to watch the latest run-up, there has been absolutely (ABSOLUTELY) nothing but conjecture to support it. The bashers and pumpers are still doing their jobs but they sound like Trump.. all talking points, no facts. Can someone explain why the volume has been so high? You can't say it's shorts covering. Non-retail shorts tend to be very well connected and educated and, from what I can see, there has been nothing to support this latest run-up, so the shorts probably see this as an anomaly and are not in cover mode because they will expect this run-up to crash. When do the short numbers come out? the proof will be in those numbers.